Correlation Between Pasithea Therapeutics and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Pasithea Therapeutics and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Acrivon Therapeutics,.
Diversification Opportunities for Pasithea Therapeutics and Acrivon Therapeutics,
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pasithea and Acrivon is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Acrivon Therapeutics,
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Acrivon Therapeutics,. In addition to that, Pasithea Therapeutics is 1.03 times more volatile than Acrivon Therapeutics, Common. It trades about -0.03 of its total potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.01 per unit of volatility. If you would invest 1,250 in Acrivon Therapeutics, Common on August 30, 2024 and sell it today you would lose (498.00) from holding Acrivon Therapeutics, Common or give up 39.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Pasithea Therapeutics |
| Acrivon Therapeutics, |
Pasithea Therapeutics and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Acrivon Therapeutics,
The main advantage of trading using opposite Pasithea Therapeutics and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
| Acrivon Therapeutics, vs. Bright Minds Biosciences | Acrivon Therapeutics, vs. HP Inc | Acrivon Therapeutics, vs. Intel | Acrivon Therapeutics, vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |